142 related articles for article (PubMed ID: 28927939)
21. Alisertib induces cell cycle arrest and autophagy and suppresses epithelial-to-mesenchymal transition involving PI3K/Akt/mTOR and sirtuin 1-mediated signaling pathways in human pancreatic cancer cells.
Wang F; Li H; Yan XG; Zhou ZW; Yi ZG; He ZX; Pan ST; Yang YX; Wang ZZ; Zhang X; Yang T; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():575-601. PubMed ID: 25632225
[TBL] [Abstract][Full Text] [Related]
22. Salinomycin efficiency assessment in non-tumor (HB4a) and tumor (MCF-7) human breast cells.
Niwa AM; D Epiro GF; Marques LA; Semprebon SC; Sartori D; Ribeiro LR; Mantovani MS
Naunyn Schmiedebergs Arch Pharmacol; 2016 Jun; 389(6):557-71. PubMed ID: 26932586
[TBL] [Abstract][Full Text] [Related]
23. Breast cancer stem cell selectivity of synthetic nanomolar-active salinomycin analogs.
Huang X; Borgström B; Kempengren S; Persson L; Hegardt C; Strand D; Oredsson S
BMC Cancer; 2016 Feb; 16():145. PubMed ID: 26906175
[TBL] [Abstract][Full Text] [Related]
24. Danthron suppresses autophagy and sensitizes pancreatic cancer cells to doxorubicin.
Chen H; Zhao C; He R; Zhou M; Liu Y; Guo X; Wang M; Zhu F; Qin R; Li X
Toxicol In Vitro; 2019 Feb; 54():345-353. PubMed ID: 30389604
[TBL] [Abstract][Full Text] [Related]
25. Biological activity of doubly modified salinomycin analogs - Evaluation in vitro and ex vivo.
Antoszczak M; Urbaniak A; Delgado M; Maj E; Borgström B; Wietrzyk J; Huczyński A; Yuan Y; Chambers TC; Strand D
Eur J Med Chem; 2018 Aug; 156():510-523. PubMed ID: 30025346
[TBL] [Abstract][Full Text] [Related]
26. Semi-synthetic salinomycin analogs exert cytotoxic activity against human colorectal cancer stem cells.
Klose J; Kattner S; Borgström B; Volz C; Schmidt T; Schneider M; Oredsson S; Strand D; Ulrich A
Biochem Biophys Res Commun; 2018 Jan; 495(1):53-59. PubMed ID: 29107689
[TBL] [Abstract][Full Text] [Related]
27. The cancer stem cell selective inhibitor salinomycin is a p-glycoprotein inhibitor.
Riccioni R; Dupuis ML; Bernabei M; Petrucci E; Pasquini L; Mariani G; Cianfriglia M; Testa U
Blood Cells Mol Dis; 2010 Jun; 45(1):86-92. PubMed ID: 20444629
[TBL] [Abstract][Full Text] [Related]
28. The anti-malarial chloroquine suppresses proliferation and overcomes cisplatin resistance of endometrial cancer cells via autophagy inhibition.
Fukuda T; Oda K; Wada-Hiraike O; Sone K; Inaba K; Ikeda Y; Miyasaka A; Kashiyama T; Tanikawa M; Arimoto T; Kuramoto H; Yano T; Kawana K; Osuga Y; Fujii T
Gynecol Oncol; 2015 Jun; 137(3):538-45. PubMed ID: 25842161
[TBL] [Abstract][Full Text] [Related]
29. Antitumor properties of salinomycin on cisplatin-resistant human ovarian cancer cells in vitro and in vivo: involvement of p38 MAPK activation.
Zhang B; Wang X; Cai F; Chen W; Loesch U; Zhong XY
Oncol Rep; 2013 Apr; 29(4):1371-8. PubMed ID: 23338561
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of Autophagy by Deguelin Sensitizes Pancreatic Cancer Cells to Doxorubicin.
Xu XD; Zhao Y; Zhang M; He RZ; Shi XH; Guo XJ; Shi CJ; Peng F; Wang M; Shen M; Wang X; Li X; Qin RY
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28208617
[TBL] [Abstract][Full Text] [Related]
31. Targeting breast cancer stem cells in triple-negative breast cancer using a combination of LBH589 and salinomycin.
Kai M; Kanaya N; Wu SV; Mendez C; Nguyen D; Luu T; Chen S
Breast Cancer Res Treat; 2015 Jun; 151(2):281-94. PubMed ID: 25904215
[TBL] [Abstract][Full Text] [Related]
32. Salinomycin enhances doxorubicin sensitivity through reversing the epithelial-mesenchymal transition of cholangiocarcinoma cells by regulating ARK5.
Yu Z; Cheng H; Zhu H; Cao M; Lu C; Bao S; Pan Y; Li Y
Braz J Med Biol Res; 2017 Aug; 50(10):e6147. PubMed ID: 28832761
[TBL] [Abstract][Full Text] [Related]
33. Effects of salinomycin and 17‑AAG on proliferation of human gastric cancer cells in vitro.
Zhang Z; Zhao J; Mi Z; Pang Q; Wang A; Chen M; Liu X; Wei X; Liu T
Mol Med Rep; 2017 Aug; 16(2):1063-1070. PubMed ID: 28627587
[TBL] [Abstract][Full Text] [Related]
34. Salinomycin inhibits the growth of colorectal carcinoma by targeting tumor stem cells.
Zhang C; Tian Y; Song F; Fu C; Han B; Wang Y
Oncol Rep; 2015 Nov; 34(5):2469-76. PubMed ID: 26352531
[TBL] [Abstract][Full Text] [Related]
35. Salinomycin enhances cisplatin-induced cytotoxicity in human lung cancer cells via down-regulation of AKT-dependent thymidylate synthase expression.
Ko JC; Zheng HY; Chen WC; Peng YS; Wu CH; Wei CL; Chen JC; Lin YW
Biochem Pharmacol; 2016 Dec; 122():90-98. PubMed ID: 27666600
[TBL] [Abstract][Full Text] [Related]
36. Salinomycin inhibits proliferation and induces apoptosis of human nasopharyngeal carcinoma cell in vitro and suppresses tumor growth in vivo.
Wu D; Zhang Y; Huang J; Fan Z; Shi F; Wang S
Biochem Biophys Res Commun; 2014 Jan; 443(2):712-7. PubMed ID: 24333874
[TBL] [Abstract][Full Text] [Related]
37. Effect of Salinomycin on Expression Pattern of Genes Associated with Apoptosis in Endometrial Cancer Cell Line.
Kiełbasiński K; Peszek W; Grabarek BO; Boroń D; Wierzbik-Strońska M; Oplawski M
Curr Pharm Biotechnol; 2020; 21(12):1269-1277. PubMed ID: 32400328
[TBL] [Abstract][Full Text] [Related]
38. Salinomycin attenuates liver cancer stem cell motility by enhancing cell stiffness and increasing F-actin formation via the FAK-ERK1/2 signalling pathway.
Sun J; Luo Q; Liu L; Yang X; Zhu S; Song G
Toxicology; 2017 Jun; 384():1-10. PubMed ID: 28395993
[TBL] [Abstract][Full Text] [Related]
39. Anticancer Activity of Polyether Ionophore-Salinomycin.
Antoszczak M; Huczyński A
Anticancer Agents Med Chem; 2015; 15(5):575-91. PubMed ID: 25553435
[TBL] [Abstract][Full Text] [Related]
40. Salinomycin enhances doxorubicin-induced cytotoxicity in multidrug resistant MCF-7/MDR human breast cancer cells via decreased efflux of doxorubicin.
Kim KY; Kim SH; Yu SN; Park SK; Choi HD; Yu HS; Ji JH; Seo YK; Ahn SC
Mol Med Rep; 2015 Aug; 12(2):1898-904. PubMed ID: 25892525
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
